Previous 10 |
Gainers: Aerie Pharmaceuticals (NASDAQ:AERI) +25%. Schrodinger (NASDAQ:SDGR) +17%. MDxHealth (NASDAQ:MDXH) +16%. Lantheus (NASDAQ:LNTH) +13%. Tabula Rasa HealthCare (NASDAQ:TRHC) +13%. Losers: Baudax Bio BXRX -55%. The Joint (NASDAQ:JYNT) -15%. Biohaven...
The following slide deck was published by MDxHealth SA in conjunction with this event. For further details see: MDxHealth (MDXH) Investor Presentation - Slideshow
MDxHealth (NASDAQ:MDXH), a recently IPO’ed molecular diagnostics company operating out of Belgium, rose sharply after drawing favorable ratings from several Wall Street analysts who initiated their coverage on the stock. Compared with traditional testing methods such as PSA tests, MDx ...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
DLA Piper advises underwriters in MDxHealth SA's IPO of American depository shares PR Newswire NEW YORK , Nov. 9, 2021 /PRNewswire/ -- DLA Piper represented Piper Sandler & Co. and Oppenheimer & Co. as lead book-running managers in the US$45 mi...
November kicked off with a 12 IPO week and shoe brand Allbirds was at the front of the flock, posting a first-day pop of 93%. 23 SPACs went public this past week led by Trine II Acquisition, which raised $360 million to target the TMT industry. Two issuers postponed this past week...
News, Short Squeeze, Breakout and More Instantly...
Mdxhealth Appoints Sanford J. Siegel, M.D. to Board of Directors IRVINE, CA, and HERSTAL, BELGIUM – July 8, 2024 ( GlobeNewswire ) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a commercial-stage precision diagnostics company, today announced the appoin...
MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance IRVINE, CA, and HERSTAL, BELGIUM – July 8, 2024 ( GlobeNewswire ) – MDxHealth SA (NASDAQ: MDXH), a commercial-stage precision diagnostics company, today reported prelimi...
Mdxhealth to Present at Upcoming Investor Conferences IRVINE, CA, and HERSTAL, BELGIUM – May 15, 2024 ( GlobeNewswire ) – Mdxhealth SA (Nasdaq: MDXH), a commercial-stage precision diagnostics company, today announced that Michael K. McGarrity, Chief Executive Officer, ...